- Home
- TBI vs SCPH Comparison
TBI vs SCPH Comparison
Compare TBI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBI
- SCPH
- Stock Information
- Founded
- TBI 1985
- SCPH 2013
- Country
- TBI United States
- SCPH United States
- Employees
- TBI N/A
- SCPH N/A
- Industry
- TBI Professional Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- TBI Consumer Discretionary
- SCPH Health Care
- Exchange
- TBI Nasdaq
- SCPH Nasdaq
- Market Cap
- TBI 169.2M
- SCPH 173.6M
- IPO Year
- TBI 1996
- SCPH 2017
- Fundamental
- Price
- TBI $6.11
- SCPH $5.50
- Analyst Decision
- TBI Buy
- SCPH Buy
- Analyst Count
- TBI 1
- SCPH 3
- Target Price
- TBI $8.00
- SCPH $12.00
- AVG Volume (30 Days)
- TBI 184.8K
- SCPH 2.1M
- Earning Date
- TBI 08-04-2025
- SCPH 08-07-2025
- Dividend Yield
- TBI N/A
- SCPH N/A
- EPS Growth
- TBI N/A
- SCPH N/A
- EPS
- TBI N/A
- SCPH N/A
- Revenue
- TBI $1,534,863,000.00
- SCPH $49,969,000.00
- Revenue This Year
- TBI $2.21
- SCPH $108.95
- Revenue Next Year
- TBI $6.18
- SCPH $78.30
- P/E Ratio
- TBI N/A
- SCPH N/A
- Revenue Growth
- TBI N/A
- SCPH 107.79
- 52 Week Low
- TBI $3.45
- SCPH $1.94
- 52 Week High
- TBI $9.05
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- TBI 46.65
- SCPH 61.89
- Support Level
- TBI $5.80
- SCPH $4.33
- Resistance Level
- TBI $6.36
- SCPH $5.62
- Average True Range (ATR)
- TBI 0.32
- SCPH 0.23
- MACD
- TBI 0.04
- SCPH 0.07
- Stochastic Oscillator
- TBI 69.15
- SCPH 90.70
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.